Primary experimental recordNegative / threshold

PMC12935919::ACT037540

Myoki

Evidence text

Paper-level observation

Section 3.1 / Figure 1A: 'Myoki does not exhibit cytotoxicity at concentrations below 500 μM' and 'negligible reduction in cell viability at concentrations up to 500 μM'.

textConfidence: medium

Assay observation

Activity

Toxicity

Subtype

Cytotoxic

Measure

cell_viability

Comparator

Raw observation

no cytotoxicity up to 500 μM

Normalized measurement

<=500 µM

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

Mus musculus

Assay method

Not reported by source

Sequence

EAEYEHL

Standardization

ready simple

Source publication

The therapeutic potential of Myoki, a novel peptide in muscle atrophy: mechanisms and applications.

Frontiers in Pharmacology · 2026

DOI 10.3389/fphar.2026.1663850 PMC12935919

Parent mention

Related peptide identities

PEPDIA-PLP-000522

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.